“Guidelines for the management of work-related asthma.” X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger, P. Maestrelli, J. Rooyackers, V. Schlünssen, O. Vandenplas and D. Wilken on behalf of the ERS Task Force on the Management of Work-related Asthma. Eur Respir J 2012; 39: 529–545.
Source: Eur Respir J 2012; 39: 1553 Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
“Guidelines for the management of work-related asthma.” X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger, P. Maestrelli, J. Rooyackers, V. Schlünssen, O. Vandenplas and D. Wilken on behalf of the ERS Task Force on the Management of Work-related Asthma. Eur Respir J 2012; 39: 529–545.. Eur Respir J 2012; 39: 1553
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
“Effect of different asthma treatments on risk of cold-related exacerbations.” H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Östlund and G.S. Eriksson. Eur Respir J 2011; 38: 584–593. Source: Eur Respir J 2012; 39: 1280 Year: 2012
“Health consequences associated with frequent wheezing in adolescents without asthma diagnosis.” K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781–786. Source: Eur Respir J 2015; 46: 1532 Year: 2015
“Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.” Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha and Alvar Agusti. Eur Respir J 2017; 49: 1700214. Source: Eur Respir J, 49 (6) 1750214; 10.1183/13993003.50214-2017 Year: 2017
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178. Source: Eur Respir J, 51 (2) 0751387; 10.1183/13993003.51387-2007 Year: 2018
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“Sleep apnoea is associated with major cardiac events in peripheral arterial disease.” Karri T. Utriainen, Juhani K. Airaksinen, Olli Polo, Ruut Laitio, Mikko J. Pietilä, Harry Scheinin, Tero Vahlberg, Kari A. Leino, Erkki S. Kentala, Jouko R. Jalonen, Harri Hakovirta, Riitta Parkkola, Sami Virtanen and Timo T. Laitio. Eur Respir J 2014; 43: 1652-1660. Source: Eur Respir J, 51 (4) 1351309; 10.1183/13993003.51309-2013 Year: 2018
“Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort” Tom M.A. Wilkinson, Emmanuel Aris, Simon C. Bourne, Stuart C. Clarke, Mathieu Peeters, Thierry G. Pascal, Laura Taddei, Andrew C. Tuck, Viktoriya L. Kim, Kristoffer K. Ostridge, Karl J. Staples, Nicholas P. Williams, Anthony P. Williams, Stephen A. Wootton and Jeanne-Marie Devaster, on behalf of the AERIS Study Group. ERJ Open Res 2019; 5: 00248-2018. Source: ERJ Open Res, 5 (3) 00248-2018-AUT; 10.1183/23120541.50248-2018 Year: 2019
“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185. Source: Eur Respir J 2016; 47:1892 Year: 2016
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373. Source: Eur Respir J 2014; 43: 1216 Year: 2014
“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373. Source: Eur Respir J, 52 (1) 1352020; 10.1183/13993003.52020-2013 Year: 2018
“Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.” M. Wilschanski, L.L. Miller, D. Shoseyov, H. Blau, J. Rivlin, M. Aviram, M. Cohen, S. Armoni, Y. Yaakov, T. Pugatch, M. Cohen-Cymberknoh, N.L. Miller, A. Reha, V.J. Northcutt, S. Hirawat, K. Donnelly, G.L. Elfring, T. Ajayi and E. Kerem. Eur Respir J 2011; 38: 59–69. Source: Eur Respir J 2011; 38: 996 Year: 2011
Author Correction: “Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways.” C.A. Hewson, J.J. Haas, N.W. Bartlett, S.D. Message, V. Laza-Stanca, T. Kebadze, G. Caramori, J. Zhu, M.R. Edbrooke, L.A. Stanciu, O.M. Kon, A. Papi, P.K. Jeffery, M.R. Edwards and S.L. Johnston. Eur Respir J 2010; 36: 1425–1435. Source: Eur Respir J 2012; 39: 793 Year: 2012
Author Correction: “Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.” M. Sester, G. Sotgiu, C. Lange, C. Giehl, E. Girardi, G.B. Migliori, A. Bossink, K. Dheda, R. Diel, J. Dominguez, M. Lipman, J. Nemeth, P. Ravn, S. Winkler, E. Huitric, A. Sandgren and D. Manissero. Eur Respir J 2011; 37: 100–111. Source: Eur Respir J 2012; 39: 793 Year: 2012
"No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559". C. Dehnert, A.M. Luks, G. Schendler, E. Menold, M.M. Berger, H. Mairbäurl, V. Faoro, D.M. Bailey, C. Castell, G. Hahn, P. Vock, E.R. Swenson and P. Bärtsch. Eur Respir J 2010; 35: 812-820. Source: Eur Respir J 2010; 36: 699 Year: 2010
Author Correction: “Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.” R. Diel, D. Goletti, G. Ferrara, G. Bothamley, D. Cirillo, B. Kampmann, C. Lange, M. Losi, R. Markova, G.B. Migliori, A. Nienhaus, M. Ruhwald, D. Wagner, J.P. Zellweger, E. Huitric, A. Sandgren and D. Manissero. Eur Respir J 2011; 37: 88–99. Source: Eur Respir J 2012; 39: 793 Year: 2012
“ERS and tobacco harm reduction.” Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman, Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco Control Committee, on behalf of the ERS. Eur Respir J 2019; 54: 1902009. Source: Eur Respir J, 55 (1) 1952009; 10.1183/13993003.52009-2019 Year: 2020
“Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness.” Kalina T. Zlateva, Jutte J.C. de Vries, Frank E.J. Coenjaerts, Anton M. van Loon, Theo Verheij, Paul Little, Christopher C. Butler, Herman Goossens, Margareta Ieven and Eric C.J. Claas on behalf of the GRACE Study Group. Eur Respir J 2014; 44: 169–177. Source: Eur Respir J 2014; 44: 556 Year: 2014
“The effect of exacerbation history on outcomes in the IMPACT trial.” David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921. Source: Eur Respir J, 55 (6) 1951921; 10.1183/13993003.51921-2019 Year: 2020
“2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS).” Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori and Marius Hoeper. Eur Respir J 2015; 46: 903–975. Source: Eur Respir J 2015; 46: 1855-1856 Year: 2015
“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230. Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018 Year: 2018